SCHEMBL7703355

SCHEMBL7703355

CCOC(=O)C1=Cc2cccc(-c3ccccc3CO)c2OCC1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PREP P48147 1/20 0.40
CYP4F2 P78329 2/20 0.40
CYP4A11 Q02928 2/20 0.40
EED O75530 2/20 0.39
ALDH1A1 P00352 5/20 0.37
GAA P10253 2/20 0.37
MAPT P10636 4/20 0.35
KDM4E B2RXH2 2/20 0.35
L3MBTL1 Q9Y468 2/20 0.35
APAF1 O14727 1/20 0.35
TDP2 O95551 1/20 0.35
NSD2 O96028 1/20 0.35
ABL1 P00519 1/20 0.35
GALK1 P51570 1/20 0.35
BLM P54132 1/20 0.35
PPP1CA P62136 1/20 0.35
RIN1 Q13671 1/20 0.35
SENP8 Q96LD8 1/20 0.35
SENP7 Q9BQF6 1/20 0.35
SENP6 Q9GZR1 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7698997 0.90 CYP4F2 (0.41) PREPCYP4F2CYP4A11EEDALDH1A1
SCHEMBL7388400 0.87 EED (0.42) PREPEEDALDH1A1GAAMAPT
SCHEMBL7697123 0.86 PREP (0.38) PREPEEDALDH1A1GAAMAPT
SCHEMBL7385304 0.82 MAPT (0.39) PREPCYP4F2CYP4A11ALDH1A1GAA
SCHEMBL7696668 0.81 CA12 (0.48) PREPCYP4F2CYP4A11ALDH1A1GAA
SCHEMBL7699846 0.81 TSHR (0.46) ALDH1A1GAAMAPTKDM4EL3MBTL1
SCHEMBL7385104 0.80 NOTUM (0.40) PREPCYP4F2CYP4A11ALDH1A1MAPT
SCHEMBL7385154 0.80 ALDH1A1 (0.43) PREPCYP4F2CYP4A11ALDH1A1GAA
SCHEMBL7386364 0.80 CA12 (0.37) PREPCYP4F2CYP4A11EEDALDH1A1
SCHEMBL7699580 0.80 ALDH1A1 (0.36) PREPCYP4F2CYP4A11ALDH1A1GAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6346527-B1 1-BENZOXEPIN DERIVATIVES USED IN THE PREVENTION OF SODIUM AND HYDROGEN ION EXCHANGE; CARDIOVASCULAR, KIDNEY AND BRAIN DISORDER TREATMENT; ARTERIOSCLEROSIS FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2002-02-12 US disclosed
EP-1073650-A1 GUANIDINE DERIVATIVES FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2001-02-07 EP disclosed
WO-1999055690-A1 GUANIDINE DERIVATIVES FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1999-11-04 WO disclosed